๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Types, causes, and therapies of hepatitis occurring in liver transplant recipients

โœ Scribed by S. Fagiuoli; G. Shah; H. I. Wright; D. H. Van Thiel

Book ID
112515262
Publisher
Springer US
Year
1993
Tongue
English
Weight
860 KB
Volume
38
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hepatitis B in liver transplant recipien
Hepatitis B in liver transplant recipients
โœ Robert G. Gish; Timothy McCashland ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire

Treatment of hepatitis C in liver transp
Treatment of hepatitis C in liver transplant recipients
โœ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant